ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,717 | -99.9% | 67,587 | +44.2% | 0.03% | -18.2% |
| Q3 2022 | $1,549,000 | +109.0% | 46,875 | +122.6% | 0.03% | +73.7% |
| Q2 2022 | $741,000 | -60.9% | 21,058 | -48.9% | 0.02% | -56.8% |
| Q1 2022 | $1,897,000 | +272.7% | 41,244 | +571.7% | 0.04% | +340.0% |
| Q2 2021 | $509,000 | -77.9% | 6,140 | -82.3% | 0.01% | -78.3% |
| Q1 2021 | $2,301,000 | +813.1% | 34,698 | +296.9% | 0.05% | +100.0% |
| Q1 2020 | $252,000 | -4.2% | 8,742 | +110.5% | 0.02% | +91.7% |
| Q4 2019 | $263,000 | +45.3% | 4,152 | -91.5% | 0.01% | +140.0% |
| Q4 2017 | $181,000 | +123.5% | 49,069 | +162.9% | 0.01% | +150.0% |
| Q3 2017 | $81,000 | -68.7% | 18,664 | -86.7% | 0.00% | -75.0% |
| Q1 2017 | $259,000 | -45.4% | 139,900 | -54.3% | 0.01% | -33.3% |
| Q4 2016 | $474,000 | – | 305,857 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |